| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.02. | Ping An Biomedical Co., Ltd. - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 12.02. | Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 30.01. | Ping An Biomedical Co., Ltd. - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 12.01. | Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| PING AN BIOMEDICAL Aktie jetzt für 0€ handeln | |||||
| 09.01. | Ping An Biomedical: Aktie stürzt nach 90-Millionen-Dollar-Investitionsplan ab | 10 | Investing.com Deutsch | ||
| 09.01. | Ping An Biomedical Co., Ltd.: Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry | 502 | GlobeNewswire (Europe) | HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") announced that it has entered into a non-binding memorandum (the... ► Artikel lesen | |
| 09.01. | Ping An Biomedical secures investment from three notable investors | 1 | Investing.com | ||
| 09.01. | Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation | 254 | GlobeNewswire (Europe) | HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") today announced that it has entered into a series of share purchase... ► Artikel lesen | |
| 28.11.25 | Ping An Biomedical receives Nasdaq letter of non-compliance | 1 | Seeking Alpha | ||
| 28.11.25 | Ping An Biomedical erhält Mängelrüge der NASDAQ wegen niedrigem Aktienkurs | 1 | Investing.com Deutsch | ||
| 28.11.25 | Ping An Biomedical receives Nasdaq minimum bid price deficiency notice | 1 | Investing.com | ||
| 28.11.25 | Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter | 125 | GlobeNewswire (Europe) | Hong Kong, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the "Company") today announced receipt of Nasdaq Minimum Bid Price Deficiency Letter. On November 24, 2025... ► Artikel lesen | |
| 28.11.25 | Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 14.10.25 | Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 26.09.25 | Majestic Ideal Holdings firmiert in Ping An Biomedical um und erhält neues NASDAQ-Kürzel | 1 | Investing.com Deutsch | ||
| 26.09.25 | Majestic Ideal Holdings Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 15.09.25 | Majestic Ideal Holdings Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.09.25 | Majestic Ideal Holdings firmiert zu Ping An Biomedical um | 2 | Investing.com Deutsch | ||
| 12.09.25 | Majestic Ideal Holdings firmiert um in Ping An Biomedical | 4 | Investing.com Deutsch | ||
| 12.09.25 | Majestic Ideal Holdings to rebrand as Ping An Biomedical | 2 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 50,90 | -0,82 % | DAX-Check: BMW, Fresenius, Hochtief, MTU, Vonovia, Zalando | Donald Trump wirbelt die Märkte mal wieder durcheinander. Der US-Präsident kündigte neue globale Zölle an. Zuvor hatte der Supreme Court die bisherigen Zollmaßnahmen für unrechtmäßig erklärt. Die Unsicherheit... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,140 | -0,59 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,220 | -5,83 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,470 | +0,64 % | DAX-Check LIVE: Aixtron, CEWE, Elmos, FMC, MTU, SFC Energy im Fokus | Neue Zolldrohungen aus Washington haben den deutschen Aktienmarkt zum Wochenstart unter Druck gesetzt. Der DAX fiel 1,06 Prozent auf 24.991 Punkte und rutschte damit wieder unter die Marke von 25.000... ► Artikel lesen | |
| GERRESHEIMER | 16,950 | +7,96 % | DAX fester, Bitcoin tiefer: FMC, MTU, IBM, Telekom, Infineon, Airbus, SAP, Gerresheimer im ... | Der DAX hat am Montag Verluste einstecken müssen. Aus dem Handel ging er mit einem Minus von 1,1 Prozent bei 24.991,97 Punkten. Der Start in den Dienstag dürfte hingegen etwas freundlicher sein. Der... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,380 | +3,14 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,120 | -0,59 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,670 | -4,10 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| OTTOBOCK | 57,00 | +1,97 % | Ottobock: Hightech-Weltmarktführer mit Comeback-Potenzial? | Die meisten deutschen Börsengänge der vergangenen Jahre verliefen für Anleger enttäuschend. Doch bei Ottobock könnte sich hinter der Kursschwäche eine langfristige Chance verbergen Den vollständigen... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,420 | +1,65 % | EQS-AFR: Eckert & Ziegler SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Eckert & Ziegler SE
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Eckert & Ziegler SE: Vorabbekanntmachung... ► Artikel lesen | |
| PROGYNY | 17,685 | -20,55 % | Progyny, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| GENEDX | 79,77 | -1,87 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| ESSILORLUXOTTICA | 225,00 | 0,00 % | Ray-Ban Meta: Preisfrage sorgt offenbar für Spannungen | ||
| ONEMEDNET | 1,030 | +53,27 % | OneMedNet-Aktie steigt nach Plattform-Launch um 90 % | ||
| PRIVIA HEALTH GROUP | 23,730 | -4,81 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen |